Skip to main content

What the FDA labels say about taking them together

Lidocaine and raloxifene

Raloxifene's FDA label of April 14, 2026 names lidocaine in its drug interactions section; the lidocaine labels PlainMeds reads (4) do not name raloxifene.

Check it at the source: the lidocaine FDA label on DailyMed (effective May 13, 2024, Fresenius Kabi USA, LLC); the raloxifene FDA label on DailyMed (effective April 14, 2026, Amneal Pharmaceuticals LLC).

What does the lidocaine label say about raloxifene?

Lidocaine's label (effective May 13, 2024) and its 3 other brand-application labels do not name raloxifene in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xylocaine MPF), Fresenius Kabi USA, LLC, effective May 13, 2024 (SPL set d5e0d06f-ba1e-44d4-aa89-39d6c146dc23), via openFDA; the full label on DailyMed

What does the raloxifene label say about lidocaine?

Raloxifene label, drug interactions

Raloxifene hydrochloride should be used with caution with certain other highly protein-bound drugs such as diazepam, diazoxide, and lidocaine.

Source: FDA drug label (Evista, NDA020815), Eli Lilly and Company, effective February 11, 2026 (SPL set fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9), via openFDA

Source: FDA drug label (Raloxifene Hydrochloride), Amneal Pharmaceuticals LLC, effective April 14, 2026 (SPL set 3798c70b-a4b0-4811-9788-e4c9cff47ebe), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

81Lidocaine generic labelers
17Raloxifene generic labelers
LidocaineRaloxifene
Labeled forPainOsteoporosis, Breast cancer
Boxed warningNoYes
Pharmacy cost (NADAC)$0.154 per gram 5% ointment$0.223 per tablet 60 mg tablet
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?